文档介绍：深圳生物医药产业投资环境与发展规划
深圳市科技和信息局
Shenzhen Bureau of Science, Technology & Information
Jan. 20, 2006
中国生命科学高峰论坛
China Life Sciences Partnering Forum--Shenzhen
Investment environment and development planning for Shenzhen Biomedicine Industry
12/8/2017
内容提要 Content
深圳市生物医药产业发展的历史回顾
Review of the development of Shenzhen’s biomedicine industry
深圳市生物医药产业腾飞的现实机遇
Present opportunity for rapid development of Shenzhen’s biomedicine industry
深圳市生物医药“十一五”期间发展目标
Development objective of Shenzhen’s biomedicine during the period of “Eleventh Five-Year Plan”
深圳市生物医药“十一五”规划四大重点支持领域
key support fields for Shenzhen’s biomedicine during the “Eleventh Five-Year Plan” planning
深圳市发展生物医药产业的工作重点
Key points for developing Shenzhen’s biomedicine industry
2
十五期间深圳生物医药产业已形成良好的产业基础
Shenzhen’s biomedicine industry has formed a fine industrial foundation during
the period of “Tenth Five-Year Plan”
2003年产值位居全国大中城市第3位;
Output value in 2003 ranked 3rd among China’s big and medium cities.
(含部分保健品)129亿元,较上年增长14%,医疗器械产品41亿元,较上年增长54%;
Output value in 2004 was billion yuan, there into medicine (including health products) are billion, up by 14% over the previous year; medical instruments, up by 54% over the previous year;
.: Sanofi Aventis, Siemens, Jincun Pharmacy, Olympus, Avail Medical Products, Inc. and PerkinElmer;
.: 999, Joincare, Mindray, Neptunus, Accord, Kexing, Kangtai and Shangrong.
3
深圳市生物医药产业发展的历史回顾一 Review 1 of the development of Shenzhen’s biomedicine industry
一批跨国生物企业在深建有生产基地
A batch of multi-national biology enterprises have set up production bases at Shenzhen;
如:赛诺菲安万特(sanofi aventis)、西门子、津村药业、奥林
巴斯、美国安卫医仪、珀金-埃尔默等
.: Sanofi Aventis, Siemens, Jincun Pharmacy, Olympus,
Avail Medical Products, Inc. and PerkinElmer;
十五期间深圳生物医药产业已形成良好的产业基础
Shenzhen’s biomedicine industry has formed a fine industrial foundation during
the period of “Tenth Five-Year Plan”
4
深圳市生物医药产业发展的历史回顾一 Review 1 of the development of Shenzhen